COVID-19 vaccination guidelines for patients with multiple sclerosis

N. V. Khachanova; N. A. Totolyan; Ya. V. Vlasov; S. A. Sivertseva; M. V. Davydovskaya; E. P. Evdoshenko; A. P. Prodeus; M. N. Zakharova; N. N. Spirin; A. N. Boyko

doi:10.14412/2074-2711-2021-2-157-161

Неврология, нейропсихиатрия, психосоматика (Apr 2021)

COVID-19 vaccination guidelines for patients with multiple sclerosis

N. V. Khachanova,
N. A. Totolyan,
Ya. V. Vlasov,
S. A. Sivertseva,
M. V. Davydovskaya,
E. P. Evdoshenko,
A. P. Prodeus,
M. N. Zakharova,
N. N. Spirin,
A. N. Boyko

Affiliations

N. V. Khachanova: Department of Neurology, Neurosurgery, and Medical Genetics, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
N. A. Totolyan: Department of Neurology, Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Ya. V. Vlasov: Department of Neurology and Neurosurgery, Samara State Medical University, Ministry of Health of Russia; All-Russian Public Organization of Disabled People with Multiple Sclerosis (PwMS RPO)
S. A. Sivertseva: Tyumen Regional Center for Multiple Sclerosis; All-Russian Public Organization «Russian Committee for Treatment and Research in Multiple Sclerosis (RUCTRIMS)»
M. V. Davydovskaya: Department of Neurology, Neurosurgery, and Medical Genetics, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Medical Association of Physicians and Centers for Multiple Sclerosis and Other Neuroimmunological Diseasesеs (MAPMS)
E. P. Evdoshenko: City Clinical Hospital Thirty-One, City Center for Multiple Sclerosis Treatment
A. P. Prodeus: G.N. Speranskiy Children Hospital №9, Moscow Healthcare Department
M. N. Zakharova: 6th neurology unit, Research Center of Neurology, Ministry of Education and Science of Russia
N. N. Spirin: All-Russian Public Organization «Russian Committee for Treatment and Research in Multiple Sclerosis (RUCTRIMS)»; Department of Neurology, Medical Genetics and Neurosurgery, Yaroslavl State Medical University, Ministry of Health of Russia
A. N. Boyko: Department of Neurology, Neurosurgery, and Medical Genetics, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; All-Russian Public Organization «Russian Committee for Treatment and Research in Multiple Sclerosis (RUCTRIMS)»; Institute of Clinical Neurology, Federal Center for Brain and Neurotechnology, FMBA of Russia

DOI: https://doi.org/10.14412/2074-2711-2021-2-157-161
Journal volume & issue: Vol. 13, no. 2
pp. 157 – 161

Abstract

Read online

The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccines. Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying therapies.

Published in Неврология, нейропсихиатрия, психосоматика

ISSN: 2074-2711 (Print); 2310-1342 (Online)
Publisher: IMA-PRESS LLC
Country of publisher: Russian Federation
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: http://nnp.ima-press.net/index.php/nnp

About the journal

Abstract

Keywords